Using a smartphone app to improve arthritis care
Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits (An Electronic Health Record Integrated Application for Psoriatic Arthritis Patient Reported Outcomes) (RAPID-PsA)
NA · Brigham and Women's Hospital · NCT06004700
This study is testing a smartphone app for people with Psoriatic Arthritis to see if it can help them communicate better with their doctors and reduce the number of visits while still getting good care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Brigham and Women's Hospital (other) |
| Drugs / interventions | guselkumab, infliximab, golimumab, ustekinumab |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06004700 on ClinicalTrials.gov |
What this trial studies
This study aims to test a smartphone app designed for patients with Psoriatic Arthritis (PsA) by integrating it into the electronic health record (EHR) system. The app will allow patients to report their symptoms and treatment responses, facilitating better communication with their healthcare team. The study will compare visit frequency and timeliness of care between patients using the app and a control group over a 12-month period. The goal is to determine if the app can reduce the number of visits while improving the quality of care.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with PsA who are currently using specific biologic treatments and have access to a smartphone.
Not a fit: Patients who do not plan to continue follow-up care at the participating center will not benefit from this study.
Why it matters
Potential benefit: If successful, this app could enhance patient care by reducing unnecessary visits and improving treatment outcomes for those with PsA.
How similar studies have performed: Other studies have shown promise in using mobile health applications to improve patient outcomes in chronic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be diagnosed with PsA by a board-certified rheumatologist and been seen at least twice in the prior year * Own a smartphone with either an Android or iPhone operating system * Be at least 18 years old * Be English-speaking * Using guselkumab, infliximab, golimumab or ustekinumab Exclusion Criteria: * Patients who do not plan on receiving follow-up care at the Brigham and Women's Arthritis Center will be excluded.
Where this trial is running
Boston, Massachusetts
- Brigham and Women's Hospital — Boston, Massachusetts, United States (RECRUITING)
Study contacts
- Study coordinator: Jacklyn Stratton
- Email: jstratton1@bwh.harvard.edu
- Phone: 617-525-8784
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Arthritis, Psoriatic Arthritis, Mobile Health